WO2023152220 - IMPROVED EXPRESSION OF RECOMBINANT PROTEINS
National phase entry:
Publication Number
WO/2023/152220
Publication Date
17.08.2023
International Application No.
PCT/EP2023/053190
International Filing Date
09.02.2023
Title **
[English]
IMPROVED EXPRESSION OF RECOMBINANT PROTEINS
[French]
EXPRESSION AMÉLIORÉE DE PROTÉINES RECOMBINANTES
Applicants **
NOVOZYMES A/S
Krogshoejvej 36
2880 Bagsvaerd, DK
Inventors
KALLEHAUGE, Thomas, Krogh
Krogshoejvej 36
2880 Bagsvaerd, DK
Priority Data
PA202200112
10.02.2022
DK
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter II
* |
| * | |
| * | |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 1882 | |
| EPO | Filing, Examination | 7543 | |
| Japan | Filing | 591 | |
| South Korea | Filing | 575 | |
| USA | Filing, Examination | 4960 |
Total: 15551 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
The present invention relates to signal peptides, signal peptide-linkers, fusion polypeptides comprising signal peptide-linker, and polynucleotides encoding the signal peptides, signal peptide-linkers, and fusion polypeptides, and to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing the fusion polypeptides, and methods for increasing secretion of a polypeptide of interest.[French]
La présente invention concerne des peptides signal, des lieurs peptidiques signal, des polypeptides de fusion comprenant un peptide-lieur signal, et des polynucléotides codant pour les peptides signal, des lieurs peptidiques signal et des polypeptides de fusion, et des constructions d'acide nucléique, des vecteurs et des cellules hôtes comprenant les polynucléotides ainsi que des procédés de production des polypeptides de fusion, et des procédés pour augmenter la sécrétion d'un polypeptide d'intérêt.